Amplifyer Bio

Lexington, United States Founded: 2023 • Age: 3 yrs
Developer of liquid biopsy solutions for early cancer detection and monitoring
Annual revenue - Latest available
Total funding $7.1M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Amplifyer Bio

Amplifyer Bio is a company based in Lexington (United States) founded in 2023. Amplifyer Bio has raised $7.08 million across 1 funding round. Amplifyer Bio operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.

  • Headquarter Lexington, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $7.08 M (USD)

    in 1 rounds

  • Latest Funding Round
    $7.08 M (USD), Series A

    Sep 27, 2024

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Amplifyer Bio

Amplifyer Bio has successfully raised a total of $7.08M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.08 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Amplifyer Bio

Investments
Premium access

Investment portfolio details for Amplifyer Bio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Amplifyer Bio

Premium access

Detailed financials for Amplifyer Bio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Amplifyer Bio Comparisons

Amplifyer Bio Primary company
Description
Developer of liquid biopsy solutions for early cancer detect...
Location
Lexington, United States
Founded Year
2023
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Amplifyer Bio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Amplifyer Bio

Amplifyer Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Digital sequencing technology for cancer detection is developed.
Locked Locked Locked
Circulating tumor DNA is screened for early cancer detection.
Locked Locked Locked
Developer of cell-free DNA testing for oncology, women’s health, and organ health
Locked Locked Locked
Genomics-based diagnostic tests for cancer are provided.
Locked Locked Locked
Molecular cancer diagnostic products are developed using patented AMP technology.
Locked Locked Locked
Health risks are identified through online genetic and diagnostic testing.
Premium access

Detailed competitors of Amplifyer Bio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Amplifyer Bio

Premium access

Complete news archive for Amplifyer Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amplifyer Bio

Amplifyer Bio was founded in 2023 and raised its 1st funding round 1 year after it was founded.

Amplifyer Bio is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Amplifyer Bio is a funded company, having raised a total of $7.08M across 1 funding round to date.

Founded in 2023 and based in Lexington, United States, Amplifyer Bio operates in the biotechnology sector focused on oncology diagnostics. A platform is provided that incorporates priming agents alongside existing liquid biopsy methods to analyze cell-free DNA in blood samples. This approach supports early detection and ongoing monitoring of cancer, with operations centered on advancing non-invasive diagnostic tools for clinical use.

Amplifyer Bio's top competitors include Guardant Health, GRAIL and Foundation Medicine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available